The present retrospective study was based on the hypothesis that increased blood FAM19A5 would reflect neuroinflammation and neurodegeneration in PD patients, and thus plasma FAM19A5 levels in PD patients are related to depressive symptoms. The gene discussed is TAFA5; the disease is Parkinson disease.